Sensus Healthcare, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Sensus Healthcare, Inc. (SRTS) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$6.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$3.76M.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$2.98M.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$8.42M.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$6.18M, a 133.75% decline year-over-year.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $27.00K.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$1.09M.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$2.37M, a 121.56% decline from fiscal 2022.
- Sensus Healthcare, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $11.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.90M 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$3.76M 10-Q · filed 2026-05-13 | ||||||
| 2025-12-31 | $27.00K 10-K · filed 2026-03-04 | ||||||
| 2025-09-30 | $2.40M 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | $106.00K 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | -$2.98M 10-Q · filed 2026-05-13 | ||||||
| 2024-12-31 | -$1.09M 10-K · filed 2026-03-04 | ||||||
| 2024-09-30 | -$590.00K 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$4.18M 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$8.42M 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | -$2.37M 10-K · filed 2025-03-05 | ||||||
| 2023-09-30 | -$5.03M 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$5.47M 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$6.18M 10-Q · filed 2024-05-10 | ||||||
| 2022-12-31 | $11.00M 10-K · filed 2024-03-15 | ||||||
| 2022-09-30 | $23.06M 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $19.18M 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | $18.31M 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | -$388.00K 10-K · filed 2023-03-23 | ||||||
| 2021-09-30 | $1.48M 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $297.00K 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | $6.81M 10-K · filed 2022-03-25 | $6.81M 10-K · filed 2021-03-05 | |||||
| 2020-09-30 | $8.03M 10-Q · filed 2021-11-10 | $8.03M 10-Q · filed 2020-11-10 | |||||
| 2020-06-30 | $10.31M 10-Q · filed 2021-08-13 | $10.31M 10-Q · filed 2020-08-10 | |||||
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-14 | ||||||
| 2019-12-31 | -$4.38M 10-K · filed 2021-03-05 | ||||||
| 2019-09-30 | -$5.58M 10-Q · filed 2020-11-10 | ||||||
| 2019-06-30 | -$1.05M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |